This finding suggests that IL28B polymorphism may play some role in favouring the development of hepatic steatosis in CT/TT patients only in the presence of active HCV replication, and such lipid metabolism disturbance is presumably mediated by the poor control on HCV replication that patients with the unfavourable IL28B genotype exert. Here, IFNL3 is linked to Hepatic steatosis.